- Our World
- Our Business
- Life at Lupin
- Global Sites
The Philippines pharmaceutical market scaled USD 3.5 billion in 2016, growing 5.5% in constant currency terms. The Company’s subsidiary in the Philippines, Multicare Pharmaceuticals Philippines Inc. (Multicare) is ranked 21st and is the fastest growing generic company in the country. Multicare is a premium branded generics company which improved its position to Rank No. 5 among its peers (branded generic), and ranked 18th among the leading pharmaceutical companies in the country with a strong presence in Diabetes, Women’s Health, Pediatrics, Respiratory, Central Nervous System and Oncology.
The Company had a strong year with revenues of PHP 1,969 million (Rs.2,741 million) growing at 23% compared to the previous year.